Earnings per ordinary share for the quarter was NT$1.54. Earnings per ADS was US$0.251. The basic weighted average number of shares outstanding in 4Q22 was 12,348,880,384, compared with 12,305,516,644 shares in 3Q22 and 12,254,114,875 shares in 4Q21. The diluted weighted average number of shares outstanding was 12,684,106,050 in 4Q22, compared with 12,635,661,561 shares in 3Q22 and 12,489,949,678 shares in 4Q21. The fully diluted shares counted on December 31, 2022 were approximately 12,684,106,000.
1Unless otherwise stated, all financial figures discussed in this announcement are prepared in accordance with TIFRSs recognized by Financial Supervisory Commission in the ROC, which is different from IFRSs issued by the International Accounting Standards Board. They represent comparisons among the three-month period ending December 31, 2022, the three-month period ending September 30, 2022, and the equivalent three-month period that ended December 31, 2021. For all 4Q22 results, New Taiwan Dollar (NT$) amounts have been converted into U.S. Dollars at the December 31, 2022 exchange rate of NT$ 30.70 per U.S. Dollar.
Detailed Financials Section
Operating revenues decreased to NT$67.84 billion. COGS declined 2.6% to NT$38.71 billion, which included 7.5% sequential decrease in depreciation. Gross profit fell 18.3% QoQ to NT$29.12 billion. Operating expenses remained flat at NT$6.80 billion, as Sales & Marketing reduced 10.2% to NT$0.95 billion while R&D was up 3.1% QoQ to NT$3.41 billion, representing 5.0% of revenue. Net other operating income was NT$1.31 billion. In 4Q22, operating income declined 21.6% QoQ to NT$23.64 billion.
COGS & Expenses |
|||||
(Amount: NT$ million) |
4Q22 |
3Q22 |
QoQ %
|
4Q21 |
YoY %
|
Operating Revenues |
67,836 |
75,392 |
(10.0) |
59,100 |
14.8 |
COGS |
(38,712) |
(39,728) |
(2.6) |
(35,997) |
7.5 |
Depreciation |
(8,898) |
(9,622) |
(7.5) |
(10,122) |
(12.1) |
Other Mfg. Costs |
(29,814) |
(30,106) |
(1.0) |
(25,875) |
15.2 |
Gross Profit |
29,124 |
35,664 |
(18.3) |
23,103 |
26.1 |
Gross Margin (%) |
42.9% |
47.3% |
|
39.1% |
|
Operating Expenses |
(6,798) |
(6,794) |
0.1 |
(6,821) |
(0.3) |
G&A |
(2,438) |
(2,428) |
0.4 |
(2,164) |
12.7 |
Sales & Marketing |
(953) |
(1,061) |
(10.2) |
(1,240) |
(23.1) |
R&D |
(3,407) |
(3,304) |
3.1 |
(3,414) |
(0.2) |
| Expected Credit Impairment Loss |
(0) |
(1) |
(48.5) |
(3) |
(88.3) |
| Net Other Operating Income & Expenses |
1,311 |
1,287 |
1.9 |
1,334 |
(1.7) |
| Operating Income |
23,637 |
30,157 |
(21.6) |
17,616 |
34.2 |
